Clinical trials success rates — it’s tougher than you think
Clinical trials are very difficult and mostly end in failure. Pharmaceutical companies have a 10% chance of getting approval of a new drug.
Lifetime lover of science, especially biomedical research. Spent years in academics, business development, research, and traveling the world shilling for Big Pharma. I love sports, mostly college basketball and football, hockey, and baseball. I enjoy great food and intelligent conversation. And a delicious morning coffee!
Clinical trials are very difficult and mostly end in failure. Pharmaceutical companies have a 10% chance of getting approval of a new drug.
NFL football player Damar Hamlin suffers a cardiac arrest on the field. Anti-vaxxers try to blame the COVID-19 vaccines, and they are wrong.
New information from the CDC show that pediatric flu deaths are the highest since the start of the pandemic.
These are the top 10 articles that I published in 2022 based on viewership. They are all very interesting for the reader.
A happy Festivus, Christmas, Chanukah, and Kwanza to all of the loyal readers of this blog. And I hope you have a great 2023.
There are numerous medical claims for cannabis. We review these claims and find out which are supported by clinical evidence.
Let’s call it science-based medicine, not allopathic, Western, or conventional medicine. Those are pejorative terms with no meaning.
There was a measles outbreak in Ohio. Of course, almost all of these children did not get their MMR vaccine to prevent it.
A new book, “The War on Ivermectin” by Pierre Kory is about to be published. Ivermectin does not work, and that’s supported by science.
This is my last push for contributions before Christmas and Festivus. Please help out the Skeptical Raptor on GoFundMe.